Bacil Pharma Limited (BOM:524516)
India · Delayed Price · Currency is INR 50.03
-1.06 (-2.07%)
At close: May 29, 2026
Bacil Pharma Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
2
Market Cap
718.08M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | - | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kimia Biosciences | 1.17B |
| Smruthi Organics | 1.02B |
| Resonance Specialties | 918.89M |
| Tyche Industries | 628.56M |
| Vasundhara Rasayans | 386.27M |
| Accretion Nutraveda | 337.16M |
| Auro Laboratories | 327.49M |
| Crestchem | 266.14M |
Bacil Pharma News
- 10 days ago - Bacil Pharma Quarterly report: Q4 2026 - Filings
- 3 months ago - Bacil Pharma Quarterly report: Q3 2026 - Filings
- 7 months ago - Bacil Pharma Quarterly report: Q2 2026 - Filings
- 10 months ago - Bacil Pharma Quarterly report: Q1 2026 - Filings